Montefiore Health System Inc.

“Montefiore Medicine Academic Health System, Inc. is the sole member of Montefiore Health System, Inc.”

“The Board of Trustees of the Montefiore Medicine Academic Health System, Inc., the sole member of Montefiore Health System, Inc., has the authority to appoint the Board of Trustees of Montefiore Health System, Inc.”

“The form 990 was prepared by Montefiore's Finance Department with the assistance of various departments. The form 990 was reviewed and approved by the Vice-president-Finance and Montefiore's senior leadership team including the chief financial officer. In addition, an independent accounting firm was engaged to review the form 990. Upon completion of the various reviews, the form 990 was presented to the board of trustees for review and approval.”

“The organization regularly and consistently monitors and enforces compliance with the disclosure policy by means of a survey form developed by counsel and approved by the Legal and Compliance Committees of the Board of Trustees. The survey is sent to all trustees, officers and key employees for completion. All survey responses are reviewed by the compliance officer. Any potential conflicts identified in the responses are discussed with senior management and/or the Legal and Compliance Committees of the Board of Trustees. Potential actions to be taken in response to a conflict would be one or more of the following: 1)Disclosure of conflict; 2)Individual recusal from decisions for transactions where that individual may have a conflict; 3) Request the individual to alleviate the conflict; or 4)Removal of the individual from the Board of Trustees.”

“Montefiore Health System, Inc. is committed to ensuring that its executive compensation program adheres to the highest standards of regulatory compliance and best corporate governance. The Board of Trustees has charged the Compensation Committee of the Board (which is comprised of independent Board members with no conflicts of interest in regards to executive compensation) with making all decisions related to compensation for officers and key employees. All decisions made by the Compensation Committee are appropriately and timely documented in meeting minutes. The compensation committee's review process follows the Intermediate Sanctions guidelines for qualifying for the rebuttable presumption of reasonableness. The Committee retains an independent compensation consultant to assist it with this process. Compensation levels are established considering data for comparable organizations, an assessment of management performance (including the services provided to the community), and other business judgment factors, consistent with Montefiore's executive compensation philosophy. The Committee's decisions are made in the best interest of Montefiore, and are intended to ensure the recruitment and retention of key executive talent, consistent with the market practices of other not-for-profit healthcare organizations of comparable scope, mission and complexity. On an annual basis, the Committee provides the full Board of Trustees with a description of the committee's review and approval process and its decisions.”

“The conflicts of interest policy and governing documents are made available upon request.”

“Montefiore SS Holdings, LLC, Montfiore MV Holdings, LLC and Montefiore HA Holdings, LLC, disregarded entities of Montefiore Health System, Inc., are the holding companies established in 2013 to own the land and buildings leased to Montefiore New Rochelle Hospital, Montefiore Mount Vernon Hospital and the Schaffer Extended Care Center, respectively. These 501(c)(3) organizations are supported entities of Montefiore Health System, INC. and are comprised of two hospitals and a nursing Home. Form 990, Part VI, Section A, Line 2 David C. Gottlieb (trustee - resigned 6/15) is related to Jay B. Langner (trustee) - Family relationship.”

“The Other increase in net assets of $237,259,000 was due to the following: - Acquisition of investment in White Plains Hospital Medical Center $141,366,000 - Adjustment of Investment in Nyack Hospital ($212,000) - Intercompany Equity transfers $104,805,000 - Changes in intercompany balance ($8,700,000)”